Corpus ID: 40646030

RASSF1A promoter hypermethylation as a prognostic marker for hepatocellular carcinoma.

@article{Saelee2010RASSF1APH,
  title={RASSF1A promoter hypermethylation as a prognostic marker for hepatocellular carcinoma.},
  author={P. Saelee and S. Wongkham and S. Chariyalertsak and S. Petmitr and U. Chuensumran},
  journal={Asian Pacific journal of cancer prevention : APJCP},
  year={2010},
  volume={11 6},
  pages={
          1677-81
        }
}
  • P. Saelee, S. Wongkham, +2 authors U. Chuensumran
  • Published 2010
  • Medicine
  • Asian Pacific journal of cancer prevention : APJCP
  • This study was performed to determine whether epigenetic aberrant methylation of RASSF1A might be associated with hepatocarcinogenesis. Methylation specific-PCR was performed to identify RASSF1A promoter hypermethylation in 29 tumors and corresponding normal liver tissues. In addition, RASSF1A mRNA levels were analyzed by quantitative real-time reverse transcription-PCR. Aberrant methylation of RASSF1A was detected in 25 of 29 cases (86%), with loss of RASSF1A expression evident in 8 of 22… CONTINUE READING
    28 Citations
    Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications.
    • 23
    Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
    Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma
    • 10
    • PDF
    Quantitative analysis of APC promoter methylation in hepatocellular carcinoma and its prognostic implications
    • 10
    • PDF
    Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?
    • 33
    Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma
    • 47
    • PDF

    References

    SHOWING 1-10 OF 47 REFERENCES
    Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
    • T. Kuroki, F. Trapasso, +4 authors C. Croce
    • Biology, Medicine
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 2003
    • 62
    Value of p16INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer
    • 83
    • PDF
    Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA
    • 156
    • PDF
    High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1–DNA adduct levels in human hepatocellular carcinoma
    • 123
    Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
    • Y. Tomizawa, T. Kohno, +9 authors J. Yokota
    • Medicine, Biology
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 2002
    • 119
    • PDF
    NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
    • 54
    High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
    • 290
    • PDF